Extensive studies of ALK-dependent resistance mechanisms in NSCLC [17,78] have identified numerous mutations which in some cases are specific to a certain ALK TKI and in others are ubiquitous amongst the ALK TKIs (Table 1). This evidence concerns the gene ALK and non-small cell lung carcinoma.